Login to Your Account

Ambit 'FLT3's with IPO Again in $57.5M Filing

By Marie Powers
Staff Writer

Friday, February 22, 2013
Late Wednesday, Ambit Biosciences Inc. disclosed an S-1 filing with the SEC for an initial public offering (IPO) of its common stock, expected to trade on the Nasdaq market under the symbol "AMBI." The company is seeking to raise up to $57.5 million, though the number of shares and price range were not yet determined.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription